|Last Price$1.40||Day Change (%)16.67%|
|Open Price$1.20||Day Change ($)0.20|
|Day Range1.00–1.40||52-Week Range0.22–200.00|
As of Wed 11/25/2015 11:42:00 AM | USD
IMS Health Chairman & CEO Ari Bousbib to Speak at J.P. Morgan Ultimate Services Conference on November 10
FDA Panel Seeks Tougher Antibiotic Labels
Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.
IMS Health is on the right track for growth.
A look back at the winners and losers of the final quarter of a tumultuous year.